18th October 2021
This week’s featured articles
Dr Fiona Withey, CEO and Co-Founder, explains how UK-headquartered TrakCel identified its market niche and how its integrated technologies support the management of the international autologous and allogeneic cell, gene and immunotherapy value chain.
Through their recently expanded collaboration, Gyros Protein Technologies and Cygnus Technologies are now able to deliver a range of ready-to-use bioprocess impurity reagent sets optimized for use with the Gyrolab platform for the detection of host cell impurities from HEK 293 cells used in vaccine and viral vector manufacturing for cell and gene therapies and vaccines
The Covid-19 pandemic has exposed and affected all links across the pharmaceutical supply chain. For many decades the industry has relied heavily on a lean principle of inventory, however, this strategy reduced flexibility and the ability of our industry supply chains to absorb even minor disruptions.
Bone Therapeutics is focused on the development of innovative products to address high unmet medical needs in orthopedics and other diseases and has a diversified portfolio of cell and biologic therapies at different stages ranging from preclinical programmes in immunomodulation to mid- to late-stage clinical development for orthopedic conditions.
Life Sciences Knowledge Hub
Stay up to date with industry news
Get the latest digital magazine and up to date news delivered right to your inbox.
Inside this issue
- Drug Discovery
- Biologics/Contract Manufacture
- Continuous Manufacturing
- Cell and Gene Therapy
- Drug Delivery
- Analytical Science
- Pharma: Global Business
- Supply Chain/Distribution